These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38288040)

  • 1. Erratum: [Corrigendum] Resveratrol reverses P‑glycoprotein‑mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‑κB and p38 MAPK signaling pathways.
    Zhang R; Lu M; Zhang Z; Tian X; Wang S; Lv D
    Oncol Lett; 2024 Mar; 27(3):92. PubMed ID: 38288040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-κB and p38 MAPK signaling pathways.
    Zhang R; Lu M; Zhang Z; Tian X; Wang S; Lv D
    Oncol Lett; 2016 Nov; 12(5):4147-4154. PubMed ID: 27895784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.
    Cao L; Chen X; Xiao X; Ma Q; Li W
    Int J Oncol; 2016 Aug; 49(2):735-43. PubMed ID: 27278736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway.
    Lu Z; Zhu X; Ye Y; Fu H; Mao J
    Cytotechnology; 2021 Oct; 73(5):697-713. PubMed ID: 34629746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: [Corrigendum] Cross regulation of signaling pathways in gastrointestinal stromal tumor.
    Qi Y; Zhao W; Wang Z; Xie Q; Cao J; Meng X
    Oncol Lett; 2023 Dec; 26(6):516. PubMed ID: 37927411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: LHX6 Affects Erlotinib Resistance and Migration of
    Onco Targets Ther; 2021; 14():2337. PubMed ID: 33854331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: LHX6 Affects Erlotinib Resistance and Migration of
    Onco Targets Ther; 2021; 14():253. PubMed ID: 33469305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: TEOA inhibits proliferation and induces DNA damage of diffuse large B-cell lymphoma cells through activation of the ROS-dependent p38 MAPK signaling pathway.
    Yu X; Wang X; Wang X; Zhou Y; Li Y; Wang A; Wang T; An Y; Sun W; Du J; Tong X; Wang Y
    Front Pharmacol; 2022; 13():973989. PubMed ID: 36034812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of PI3K/Akt and p38 MAPK in the induction of COX-2 expression by bacterial lipopolysaccharide in murine adrenocortical cells.
    Mercau ME; Astort F; Giordanino EF; Martinez Calejman C; Sanchez R; Caldareri L; Repetto EM; Coso OA; Cymeryng CB
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):43-51. PubMed ID: 24424443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis".
    Wang W; Niu S; Qiao L; Wei F; Yin J; Wang S; Ouyang Y; Chen D
    Biomed Res Int; 2021; 2021():9808613. PubMed ID: 34977250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum:
    Drug Des Devel Ther; 2017; 11():2683. PubMed ID: 28979097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.
    Li J; Campanale NV; Liang RJ; Deane JA; Bertram JF; Ricardo SD
    Am J Pathol; 2006 Nov; 169(5):1527-40. PubMed ID: 17071578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells.
    Wang L; Wang C; Jia Y; Liu Z; Shu X; Liu K
    J Cell Biochem; 2016 May; 117(5):1233-9. PubMed ID: 26460589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways.
    Su Y; Wan D; Song W
    Anticancer Drugs; 2016 Aug; 27(7):660-8. PubMed ID: 27243922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.
    Mödder UI; Oursler MJ; Khosla S; Monroe DG
    J Cell Biochem; 2011 May; 112(5):1392-402. PubMed ID: 21321991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
    Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
    Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells.
    Li Y; Guo Y; Feng Z; Bergan R; Li B; Qin Y; Zhao L; Zhang Z; Shi M
    Nutr Cancer; 2019; 71(6):1007-1018. PubMed ID: 31032633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase.
    Mukherjee JJ; Sikka HC
    Carcinogenesis; 2006 Mar; 27(3):631-8. PubMed ID: 16244358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways.
    Zhang L; Zhang Z; Chen F; Chen Y; Lin Y; Wang J
    Eur J Med Chem; 2016 Nov; 123():226-235. PubMed ID: 27484511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Anti-Breast Cancer Effect of 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione in vivo and in vitro Through MAPK Signaling Pathway [Corrigendum].
    Drug Des Devel Ther; 2020; 14():4575-4577. PubMed ID: 33149554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.